-
Symbol
-
LXEO on Nasdaq
-
Investment type
-
Equity / Common Stock ($0.0001 par value) (the "Shares")
-
Latest Disclosed Shares Owned
-
3,698,271 shares
-
Security Ownership %
-
5.1%
Frazier Life Sciences Public Fund, L.P. ownership in Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO)
13 Feb 2026 - Frazier Life Sciences Public Fund, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 3,698,271 shares of Lexeo Therapeutics, Inc. Common Stock ($0.0001 par value) (the "Shares") (LXEO).
This represents 5.1% ownership of the company.
In their previous filing dated 14 Aug 2025, Frazier Life Sciences Public Fund, L.P. had reported owning 3,073,467 shares, indicating an increase of +20%.
.